Unichem Laboratories Limited reported a solid financial performance for the third quarter ended December 31, 2024 (Q3 FY25), with revenue from operations increasing by 14.4% year-on-year (YoY) to Rs 533 crore compared to Rs 465.72 crore in the corresponding quarter last year.
Key financial highlights for Q3 FY25:
- Revenue from operations: Rs 533 crore, up 14.4% YoY from Rs 465.72 crore.
- Total income: Rs 546.71 crore, compared to Rs 476.99 crore YoY.
- Net profit: Rs 57.85 crore, down 20.99% YoY from Rs 73.22 crore in same quarter last year.
- Total expenses: Rs 484.86 crore, compared to Rs 471.80 crore YoY, reflecting higher raw material and employee costs.
- Profit before tax: Rs 61.85 crore, compared to Rs 27.13 crore YoY.
The company attributed its performance to robust growth in its domestic formulations and international business segments. With a focus on expanding its product pipeline and international market penetration, Unichem aims to sustain its growth momentum.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions.
